相关实验视频
Updated: Jan 29, 2026

07:08
Modified Drop Tower Impact Tests for American Football Helmets
Published on: February 19, 2017
11.4K
与头盔治疗结果相关的因素在定位性脑衰竭中
Sumin Lee1, Eunju Na1, Joon Won Seo1
1Department of Rehabilitation Medicine, Gwangju Christian Hospital, Gwangju 61661, Republic of Korea.
Journal of clinical medicine
|January 28, 2026
概括
六个月以下的婴儿早期的头盔治疗显著改善了定位性脑症的结果. 前方方体的大小不会影响治疗的有效性,使年龄成为成功的头盔治疗的关键因素.
科学领域:
- 儿科整形医生 儿科整形医生
- 头骨的发展 头骨的发展
- 婴儿健康 婴儿健康
背景情况:
- 定位性脑症是婴儿常见的疾病.
- 头盔治疗是定位性脑症的首要治疗方法.
- 前方方体尺寸对头盔治疗结果的影响尚未得到充分证实.
研究的目的:
- 为了研究前方方体尺寸对头盔治疗有效性的影响.
- 为了确定前方方体的大小是否会影响定位脑症的治疗结果.
- 为了确定最佳的患者标准和治疗头盔的时间.
主要方法:
- 以头盔疗法治疗的94名位置性脑症婴儿的回顾性研究.
- 患者按年龄 (≤6个月 vs. >6个月) 和前方方尺寸四分位数进行分类.
- 在治疗前和治疗后测量的大脑非对称性 (CVA) 和大脑非对称性指数 (CVAI).
主要成果:
- 年龄小于6个月的婴儿在CVA和CVAI方面表现出明显的改善,这与年龄较大的婴儿相比.
- 根据前方方尺寸四分位数,没有观察到治疗结果的显著差异.
- 治疗开始时的年龄是一个比前方喷泉尺寸更关键的因素.
结论:
- 前方方体的大小并不是定位脑症中头盔治疗结果的预测指标.
- 早期启动头盔治疗 (≤6个月) 是最佳结果的最关键因素.
- 年龄,而不是前方方体大小,应该指导定位脑症的治疗决策.
相关概念视频
Predicting Reaction Outcomes
10.8K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.8K
Outcomes of Glycolysis
107.1K
Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.1K
Position-effect Variegation
7.1K
In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
7.1K
Guidelines for Writing Outcome
3.8K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.8K
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Transcription Factors
82.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K

